|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS10013 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-NDUFS2 |
| 克隆性 | |
| 靶點(diǎn) | 詳見說(shuō)明書 |
| 適應(yīng)物種 | 詳見說(shuō)明書 |
| 形態(tài) | 詳見說(shuō)明書 |
| 宿主 | 詳見說(shuō)明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見說(shuō)明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human NDUFS2 |
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：
1. NDUFS2抗體費(fèi)用 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件；
3.用NHSB量過(guò)量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合；
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用；
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
產(chǎn)品訂購(gòu)信息：
英文名稱 Anti-NDUFS2
中文名稱 NDUFS2抗體費(fèi)用
別 名 NDUS2_HUMAN; NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial; Complex I-49kD; CI-49kD; NADH-ubiquinone oxidoreductase 49 kDa subunit; NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial isoform 1 precursor; CI-49.
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit
產(chǎn)品類型 一抗
研究領(lǐng)域 線粒體
蛋白分子量 predicted molecular weight: 49kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human NDUFS2
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
NDUFS2抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The protein encoded by this gene is a core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (complex I). Mammalian mitochondrial complex I is composed of at least 43 different subunits, 7 of which are encoded by the mitochondrial genome, and the rest are the products of nuclear genes. The iron-sulfur protein fraction of complex I is made up of 7 subunits, including this gene product. Complex I catalyzes the NADH oxidation with concomitant ubiquinone reduction and proton ejection out of the mitochondria. Mutations in this gene are associated with mitochondrial complex I deficiency. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009].
Function : Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) that is believed to belong to the minimal assembly required for catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone.Subunit : Complex I is composed of 45 different subunits. Component of the iron-sulfur (IP) fragment of the enzyme. Interacts with NDUFAF3.Subcellular Location : Mitochondrion inner membrane; Peripheral membrane protein; Matrix side.DISEASE : Defects in NDUFS2 are a cause of mitochondrial complex I deficiency (MT-C1D) [MIM:252010]. A disorder of the mitochondrial respiratory chain that causes a wide range of clinical disorders, from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease.Similarity : Belongs to the complex I 49 kDa subunit family.Database links : UniProtKB/Swiss-Prot: O75306.2
抗體的鑒定：
1）NDUFS2抗體費(fèi)用 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。
2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力?？贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol?？贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。
AsAb ELISA Kit 大鼠抗抗體Multi-class antibodies規(guī)格： 48T
Anti-AE3/FITC 熒光素標(biāo)記陰離子交換蛋白3抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh FbxW2 FbxW2蛋白抗體 規(guī)格 0.2ml
TNF- Alpha(Human Tumor necrosis factor Alpha) ELISA KIT 人壞死因子α 96T
Myelin PLP 英文名稱： 髓磷酯髓鞘蛋白1抗體 0.2ml
AKAP7 英文名稱： 蛋白激酶A錨定蛋白7抗體 0.2ml
Anti-AE3/FITC 熒光素標(biāo)記陰離子交換蛋白3抗體IgGMulti-class antibodies規(guī)格： 0.2ml
CD147/EMMPRIN(Extracellular matrix metalloproteinase inducer) CD147(抗原)Multi-class antibodies規(guī)格： 0.5mg
Anti-CCL12/MCP5 單核細(xì)胞趨化蛋白5抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh PCDHA2 原鈣粘附蛋白α2抗體 規(guī)格 0.2ml
CD3D Kit Human 人 CD3d / CD3 delta ELISA配對(duì)抗體 ELISA
TM7SF2 英文名稱： 脫氫膽固醇還原酶14抗體 0.2ml
Caspase-13 + 4 英文名稱： 半胱胺酸蛋白酶蛋白-13抗體 0.2ml
Anti-CCL12/MCP5 單核細(xì)胞趨化蛋白5抗體Multi-class antibodies規(guī)格： 0.2ml
p38 MAPK/MKK3/MAPKK14 原活化蛋白激酶p38(抗原)Multi-class antibodies規(guī)格： 0.5mg
Anti-Bcr Bcr抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh PAGE1 相關(guān)P抗原家族成員1抗體 規(guī)格 0.2ml
DLL1 Kit Human 人 DLL1 ELISA配對(duì)抗體 ELISA
TANK 英文名稱： TANK抗體 0.1ml
CRTAM 英文名稱： T細(xì)胞調(diào)控相關(guān)蛋白抗體 0.2ml
Anti-Bcr Bcr抗體Multi-class antibodies規(guī)格： 0.2ml
TNFSF8 Protein Rat 重組大鼠 CD153 / CD30L / TNFSF8 蛋白
CoC2(懸浮)
CSF2 Others Human 人 GM-CSF / CSF2 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
COLO 205人細(xì)胞 COLO 205 human colon cancer cells 1640+10% FBS
人低侵襲性脈絡(luò)膜黑色素素瘤細(xì)胞;OCM-1A
人角膜成纖維細(xì)胞 (HcorF)( 5×105 ) EPC, 大鼠內(nèi)皮祖細(xì)胞 Rattus
CL-0448SW 1990(人*癌細(xì)胞)5×106cells/瓶×2
VSIG4 Others Human 人 VSIG4 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
人骨骼肌成肌細(xì)胞RNAHSkMM miRNA5 μg
ScaBER細(xì)胞，人膀胱鱗癌細(xì)胞 小鼠細(xì)胞,C26細(xì)胞 RLFs, 大鼠
L-O2(人正常肝細(xì)胞) 5×106cells/瓶×2
NHEK.f single donor Pellet 正常人表皮角質(zhì)細(xì)胞團(tuán)塊(少年者) > 1 mio.cells 小鼠顆粒細(xì)胞MGC
NDUFS2抗體費(fèi)用 TNFSF8 Protein Rat 重組大鼠 CD153 / CD30L / TNFSF8 蛋白
CoC2(懸浮)
CSF2 Others Human 人 GM-CSF / CSF2 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
COLO 205人細(xì)胞 COLO 205 human colon cancer cells 1640+10% FBS
人低侵襲性脈絡(luò)膜黑色素素瘤細(xì)胞;OCM-1A
人角膜成纖維細(xì)胞 (HcorF)( 5×105 ) EPC, 大鼠內(nèi)皮祖細(xì)胞 Rattus
|
|
|
|
